Engaging Patients Across the Spectrum of Medical Product Development: View From the US Food and Drug Administration

JAMA. 2015 Dec 15;314(23):2499-500. doi: 10.1001/jama.2015.15818.

Authors

Nina L Hunter¹, Kathryn M O'Callaghan¹, Robert M Califf²

Affiliations

¹ Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland.
² Office of Medical Products and Tobacco, US Food and Drug Administration, Silver Spring, Maryland.

PMID: 26584067
DOI: 10.1001/jama.2015.15818

No abstract available

MeSH terms

Advisory Committees / organization & administration
Biological Products*
Equipment and Supplies*
Humans
Needs Assessment*
Outcome Assessment, Health Care
Patient Participation / methods*
Pharmaceutical Preparations*
United States
United States Food and Drug Administration*

Substances

Biological Products
Pharmaceutical Preparations